{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:26:10Z","timestamp":1789503970387,"version":"build-2803163510"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04057-8","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T08:55:36Z","timestamp":1741683336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combating chronic kidney disease-associated cachexia: A literature review of recent therapeutic approaches"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3295-404X","authenticated-orcid":false,"given":"Yalda","family":"Rahbar Saadat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-0540","authenticated-orcid":false,"given":"Amin","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-1539","authenticated-orcid":false,"given":"Seyyed Sina","family":"Hejazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4683-074X","authenticated-orcid":false,"given":"Yalda","family":"Hekmatshoar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6851-5460","authenticated-orcid":false,"given":"Mohammadreza","family":"Ardalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-6881","authenticated-orcid":false,"given":"Farahnoosh","family":"Farnood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0179-4562","authenticated-orcid":false,"given":"Sepideh","family":"Zununi Vahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"4057_CR1","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K, Kopple J. Cachexia in chronic kidney disease: malnutrition-inflammation complex and reverse epidemiology. In Cachexia and wasting: a modern approach. 2006:305\u2013\u200925.","DOI":"10.1007\/978-88-470-0552-5_31"},{"issue":"4","key":"4057_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00467-012-2241-6","volume":"28","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Asakawa A, Amitani H, Nakamura N, Inui A. Ghrelin and cachexia in chronic kidney disease. Pediatr Nephrol. 2013;28(4):521\u20136.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"4057_CR3","doi-asserted-by":"publisher","first-page":"14175","DOI":"10.1038\/s41598-020-70190-z","volume":"10","author":"WW Cheung","year":"2020","unstructured":"Cheung WW, Ding W, Hoffman HM, Wang Z, Hao S, Zheng R, et al. Vitamin D ameliorates adipose browning in chronic kidney disease cachexia. Scintific Rep. 2020;10(1):14175.","journal-title":"Scintific Rep"},{"issue":"4","key":"4057_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/jcsm.13260","volume":"14","author":"M Okamura","year":"2023","unstructured":"Okamura M, Konishi M, Butler J, Kalantar-Zadeh K, von Haehling S, Anker SD. Kidney function in cachexia and sarcopenia: facts and numbers. J Cachexia Sarcopenia Muscle. 2023;14(4):1589\u201395.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"4057_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00467-006-0194-3","volume":"21","author":"RH Mak","year":"2006","unstructured":"Mak RH, Cheung W. Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol. 2006;21(12):1807\u201314.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"4057_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/jcsm.12167","volume":"7","author":"S von Haehling","year":"2016","unstructured":"von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"4057_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.0894-0959.2004.17611.x","volume":"17","author":"PLB Stenvinkel","year":"2004","unstructured":"Stenvinkel PLB, Heimb\u00fcrger O. Poor nutritional status and inflammation: novel approaches in an integrated therapy of inflammatory-associated wasting in end\u2010stage renal disease. Semin Dial. 2004;17(6):505\u201315.","journal-title":"InSeminars Dialysis"},{"issue":"4","key":"4057_CR8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MAJ.0000000000000511","volume":"350","author":"T Yoshida","year":"2015","unstructured":"Yoshida T, Delafontaine P. Mechanisms of cachexia in chronic disease states. Am J Med Sci. 2015;350(4):250\u20136.","journal-title":"Am J Med Sci"},{"issue":"4","key":"4057_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-009-1427-z","volume":"25","author":"WW Cheung","year":"2010","unstructured":"Cheung WW, Paik KH, Mak RH. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010;25(4):711\u201324.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4057_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3945\/ajcn.111.014639","volume":"94","author":"MZ Molnar","year":"2011","unstructured":"Molnar MZ, Streja E, Kovesdy CP, Budoff MJ, Nissenson AR, Krishnan M, et al. High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. Am J Clin Nutr. 2011;94(3):945\u201354.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"4057_CR11","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1172\/JCI138392","volume":"130","author":"X Zhu","year":"2020","unstructured":"Zhu X, Callahan MF, Gruber KA, Szumowski M, Marks DL. Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia. J Clin Invest. 2020;130(9):4921\u201334.","journal-title":"J Clin Invest"},{"issue":"2","key":"4057_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00467-011-1765-5","volume":"27","author":"RH Mak","year":"2012","unstructured":"Mak RH, Cheung WW, Zhan JY, Shen Q, Foster BJ. Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol. 2012;27(2):173\u201381.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"4057_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jcsm.12421","volume":"10","author":"L Koppe","year":"2019","unstructured":"Koppe L, Fouque D, Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019;10(3):479\u201384.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR14","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation\u2010cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial. 2005;18(5):365\u20139.","DOI":"10.1111\/j.1525-139X.2005.00074.x"},{"issue":"2","key":"4057_CR15","first-page":"e11","volume":"2","author":"J Reid","year":"2016","unstructured":"Reid J, Noble HR, Slee A, Davenport A, Farrington K, Fouque D, et al. Distinguishing between cachexia, sarcopenia and protein energy wasting in end-stage renal disease patients on dialysis. Palliative medicine and hospice care - Open J. 2016;2(2):e11\u20133.","journal-title":"Open J"},{"issue":"2","key":"4057_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17987\/jcsm-cr.v3i2.63","volume":"3","author":"AD Slee","year":"2018","unstructured":"Slee AD, Reid J. Wasting in chronic kidney disease\u2013a complex issue. JCSM Clin Rep. 2018;3(2):1\u201310.","journal-title":"JCSM Clin Rep"},{"issue":"1\u20132","key":"4057_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000504240","volume":"49","author":"RM Hanna","year":"2020","unstructured":"Hanna RM, Ghobry L, Wassef O, Rhee CM, Kalantar-Zadeh K. A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif. 2020;49(1\u20132):202\u201311.","journal-title":"Blood Purif"},{"issue":"1","key":"4057_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-6686.2013.00341.x","volume":"39","author":"JNH Reid","year":"2013","unstructured":"Reid JNH, Porter S, Shields JS, Maxwell AP. A literature review of end-stage renal disease and cachexia: Understanding experience to inform evidence\u2010based healthcare. J Ren Care. 2013;39(1):47\u201351.","journal-title":"J Ren Care"},{"issue":"10","key":"4057_CR19","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/ndt\/gfaa174","volume":"36","author":"C McKeaveney","year":"2021","unstructured":"McKeaveney C, Slee A, Adamson G, Davenport A, Farrington K, Fouque D, et al. Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study. Nephrol Dialysis Transplantation. 2021;36(10):1919\u201326.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"3","key":"4057_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MCO.0000000000001022","volume":"27","author":"A Slee","year":"2024","unstructured":"Slee A, Reid J. Exercise and nutrition interventions for renal cachexia. Curr Opin Clin Nutr Metabolic Care. 2024;27(3):219\u201325.","journal-title":"Curr Opin Clin Nutr Metabolic Care"},{"issue":"6","key":"4057_CR21","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI22521","volume":"115","author":"W Cheung","year":"2005","unstructured":"Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest. 2005;115(6):1659\u201365.","journal-title":"J Clin Invest"},{"issue":"6","key":"4057_CR22","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00467-005-1891-z","volume":"20","author":"R Pecoits-Filho","year":"2005","unstructured":"Pecoits-Filho R, Sylvestre LC, Stenvinkel P. Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol. 2005;20(6):714\u201320.","journal-title":"Pediatr Nephrol"},{"key":"4057_CR23","doi-asserted-by":"publisher","first-page":"2063179","DOI":"10.1155\/2018\/2063179","volume":"2018","author":"J Abrigo","year":"2018","unstructured":"Abrigo J, Elorza AA, Riedel CA, Vilos C, Simon F, Cabrera D, et al. Role of oxidative stress as key regulator of muscle wasting during Cachexia. Oxidative Med Cell Longev. 2018;2018:2063179.","journal-title":"Oxidative Med Cell Longev"},{"key":"4057_CR24","doi-asserted-by":"publisher","first-page":"115407","DOI":"10.1016\/j.bcp.2022.115407","volume":"208","author":"K Wang","year":"2023","unstructured":"Wang K, Liu Q, Tang M, Qi G, Qiu C, Huang Y, et al. Chronic kidney disease-induced muscle atrophy: molecular mechanisms and promising therapies. Biochem Pharmacol. 2023;208:115407.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4057_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-023-01365-6","volume":"9","author":"J Wu","year":"2023","unstructured":"Wu J, Lin S, Chen W, Lian G, Wu W, Chen A, et al. TNF-\u03b1 contributes to sarcopenia through caspase-8\/caspase-3\/GSDME-mediated pyroptosis. Cell Death Discovery. 2023;9(1):76.","journal-title":"Cell Death Discovery"},{"issue":"1","key":"4057_CR26","doi-asserted-by":"publisher","first-page":"15141","DOI":"10.1038\/s41598-021-94565-y","volume":"11","author":"WW Cheung","year":"2021","unstructured":"Cheung WW, Zheng R, Hao S, Wang Z, Gonzalez A, Zhou P, et al. The role of IL-1 in adipose Browning and muscle wasting in CKD-associated cachexia. Scintific Rep. 2021;11(1):15141.","journal-title":"Scintific Rep"},{"issue":"8","key":"4057_CR27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/biom11081144","volume":"11","author":"AK Aranda-Rivera","year":"2021","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Aparicio-Trejo OE, Pedraza-Chaverri J. Mitochondrial redox signaling and oxidative stress in kidney diseases. Biomolecules. 2021;11(8):1144.","journal-title":"Biomolecules"},{"issue":"2","key":"4057_CR28","doi-asserted-by":"publisher","first-page":"F161","DOI":"10.1152\/ajprenal.00437.2020","volume":"320","author":"DL Kirkman","year":"2021","unstructured":"Kirkman DL, Bohmke N, Carbone S, Garten RS, Rodriguez-Miguelez P, Franco RL, et al. Exercise intolerance in kidney diseases: physiological contributors and therapeutic strategies. Am J Physiology-Renal Physiol. 2021;320(2):F161\u201373.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"10","key":"4057_CR29","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.3390\/ijms25105117","volume":"25","author":"K Heitman","year":"2024","unstructured":"Heitman K, Alexander MS, Faul C. Skeletal muscle injury in chronic kidney Disease\u2014From histologic changes to molecular mechanisms and to novel therapies. Int J Mol Sci. 2024;25(10):5117.","journal-title":"Int J Mol Sci"},{"key":"4057_CR30","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/ndt\/gfaa129","volume":"36","author":"S Bataille","year":"2020","unstructured":"Bataille S, Chauveau P, Fouque D, Aparicio M, Koppe L. Myostatin and muscle atrophy during chronic kidney disease. Nephrol Dial Transplant. 2020;36:1986\u201393.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"4057_CR31","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.7150\/thno.29579","volume":"9","author":"B Wang","year":"2019","unstructured":"Wang B, Zhang A, Wang H, Klein JD, Tan L, Wang Z-M, et al. miR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated MicroRNA transfer in chronic kidney disease. Theranostics. 2019;9(7):1864.","journal-title":"Theranostics"},{"key":"4057_CR32","doi-asserted-by":"publisher","first-page":"859723","DOI":"10.3389\/fphar.2022.859723","volume":"13","author":"Q Li","year":"2022","unstructured":"Li Q, Wu J, Huang J, Hu R, You H-y, Liu L-y, et al. Paeoniflorin ameliorates skeletal muscle atrophy in chronic kidney disease via AMPK\/SIRT1\/PGC-1\u03b1-Mediated oxidative stress and mitochondrial dysfunction. Front Pharmacol. 2022;13:859723.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4057_CR33","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","volume":"22","author":"CA Juan","year":"2021","unstructured":"Juan CA, de la P\u00e9rez JM, Plou FJ, Perez-Lebe\u00f1a E. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and Proteins) and induced pathologies. Int J Mol Sci. 2021;22(9):4642.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4057_CR34","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/toxins13120909","volume":"13","author":"T Nakano","year":"2021","unstructured":"Nakano T, Watanabe H, Imafuku T, Tokumaru K, Fujita I, Arimura N, et al. Indoxyl sulfate contributes to mTORC1-Induced renal fibrosis via the OAT\/NADPH oxidase\/ros pathway. Toxins. 2021;13(12):909.","journal-title":"Toxins"},{"issue":"6","key":"4057_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/antiox13060687","volume":"13","author":"W Fr\u0105k","year":"2024","unstructured":"Fr\u0105k W, D\u0105bek B, Balcerczyk-Lis M, Motor J, Radzioch E, M\u0142ynarska E, et al. Role of uremic toxins, oxidative stress, and renal fibrosis in chronic kidney disease. Antioxidants. 2024;13(6):687.","journal-title":"Antioxidants"},{"issue":"18","key":"4057_CR36","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3390\/ijms21186911","volume":"21","author":"H-Y Jung","year":"2020","unstructured":"Jung H-Y, Oh S-H, Ahn J-S, Oh EJ, Kim Y-J, Kim C-D, et al. NOX1 inhibition attenuates kidney ischemia-reperfusion injury via inhibition of ROS-mediated ERK signaling. Int J Mol Sci. 2020;21(18):6911.","journal-title":"Int J Mol Sci"},{"key":"4057_CR37","first-page":"1875471","volume":"2019","author":"M Wang","year":"2019","unstructured":"Wang M, Hu R, Wang Y-j, Liu L-y, You H-y, Zhang J, et al. Atractylenolide III attenuates muscle wasting in chronic kidney disease via the oxidative stress-mediated PI3K\/AKT\/mTOR pathway. Oxidative Med Cell Longev. 2019;2019:1875471.","journal-title":"Oxidative Med Cell Longev"},{"key":"4057_CR38","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fphys.2015.00347","volume":"6","author":"PA Kramer","year":"2015","unstructured":"Kramer PA, Duan J, Qian W-J, Marcinek DJ. The measurement of reversible redox dependent Post-translational modifications and their regulation of mitochondrial and skeletal muscle function. Front Physiol. 2015;6:347.","journal-title":"Front Physiol"},{"issue":"1","key":"4057_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s11658-024-00572-y","volume":"29","author":"Y Lei","year":"2024","unstructured":"Lei Y, Gan M, Qiu Y, Chen Q, Wang X, Liao T, et al. The role of mitochondrial dynamics and mitophagy in skeletal muscle atrophy: from molecular mechanisms to therapeutic insights. Cell Mol Biol Lett. 2024;29(1):59.","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"4057_CR40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.23736\/S1121-421X.18.02511-4","volume":"64","author":"R de Sire","year":"2018","unstructured":"de Sire R, Rizzatti G, Ingravalle F, Pizzoferrato M, Petito V, Lopetuso LR, et al. Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases. Minerva Gastroenterol Dietol. 2018;64(4):351\u201362.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"4057_CR41","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1172\/JCI42447","volume":"120 11","author":"MD Mavalli","year":"2010","unstructured":"Mavalli MD, Digirolamo DJ, Fan Y-J, Riddle RC, Campbell KS, van Groen T, et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Investig. 2010;120 11:4007\u201320.","journal-title":"J Clin Investig"},{"issue":"1","key":"4057_CR42","doi-asserted-by":"publisher","first-page":"e1462","DOI":"10.1002\/wsbm.1462","volume":"12","author":"K Mukund","year":"2019","unstructured":"Mukund K, Subramaniam S. Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdisciplinary Reviews Syst Biology Med. 2019;12(1):e1462.","journal-title":"Wiley Interdisciplinary Reviews Syst Biology Med"},{"key":"4057_CR43","doi-asserted-by":"crossref","unstructured":"Wang W, Li M, Chen Z, Xu L, Chang M, Wang K et al. Biogenesis and function of extracellular vesicles in pathophysiological processes skeletal muscle atrophy. Biochem Pharmacol. 2022:114954.","DOI":"10.1016\/j.bcp.2022.114954"},{"issue":"3","key":"4057_CR44","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","volume":"311","author":"PA Bilodeau","year":"2016","unstructured":"Bilodeau PA, Coyne ES, Wing SS. The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation. Am J Physiol Cell Physiol. 2016;311(3):C392\u2013403.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4057_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-981-13-1435-3_10","volume":"1088","author":"Khalil RM","year":"2018","unstructured":"Khalil RM. Ubiquitin-Proteasome pathway and muscle atrophy. Adv Exp Med Biol. 2018;1088:235\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"4057_CR46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12272-020-01281-8","volume":"43","author":"J Park","year":"2020","unstructured":"Park J, Cho J, Song EJ. Ubiquitin\u2013proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res. 2020;43:1144\u201361.","journal-title":"Arch Pharm Res"},{"key":"4057_CR47","doi-asserted-by":"crossref","unstructured":"Yin L, Li N, Jia W-h, Wang N-q, Liang M, Yang X-y, et al. Skeletal muscle atrophy: from mechanisms to treatments. Pharmacol Res. 2021:105807.","DOI":"10.1016\/j.phrs.2021.105807"},{"key":"4057_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/978-981-15-0602-4_25","volume":"1206","author":"Y Wang","year":"2019","unstructured":"Wang Y, Le W-D. Autophagy and Ubiquitin-Proteasome system. Adv Exp Med Biol. 2019;1206:527\u201350.","journal-title":"Adv Exp Med Biol"},{"key":"4057_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-019-03021-x","volume":"378","author":"R Zheng","year":"2019","unstructured":"Zheng R, Huang S, Zhu J, Lin W, Xu H, Zheng X. Leucine attenuates muscle atrophy and autophagosome formation by activating PI3K\/AKT\/mTOR signaling pathway in rotator cuff tears. Cell Tissue Res. 2019;378:113\u201325.","journal-title":"Cell Tissue Res"},{"key":"4057_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10:504\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4057_CR51","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00018-022-04408-w","volume":"79","author":"E Abati","year":"2022","unstructured":"Abati E, Manini A, Comi GP, Corti S. Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases. Cell Mol Life Sci. 2022;79(7):374.","journal-title":"Cell Mol Life Sci"},{"key":"4057_CR52","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.cell.2022.03.028","volume":"185","author":"LM Baehr","year":"2022","unstructured":"Baehr LM, Hughes DC, Waddell DS, Bodine SC. SnapShot: skeletal muscle atrophy. Cell. 2022;185:1618\u2013e1.","journal-title":"Cell"},{"issue":"3","key":"4057_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2362.2005.01473.x","volume":"35","author":"J Du","year":"2005","unstructured":"Du J, Hu Z, Mitch WE. Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions. Eur J Clin Invest. 2005;35(3):157\u201363.","journal-title":"Eur J Clin Invest"},{"key":"4057_CR54","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","volume":"128 4","author":"J Herranz Ns, Gil","year":"2018","unstructured":"Herranz Ns, Gil J. Mechanisms and functions of cellular senescence. J Clin Investig. 2018;128 4:1238\u201346.","journal-title":"J Clin Investig"},{"key":"4057_CR55","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.csbj.2019.06.015","volume":"17","author":"L Dai","year":"2019","unstructured":"Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P. Early vascular ageing and cellular senescence in chronic kidney disease. Comput Struct Biotechnol J. 2019;17:721\u20139.","journal-title":"Comput Struct Biotechnol J"},{"key":"4057_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"VG Gorgoulis","year":"2019","unstructured":"Gorgoulis VG, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop CL, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813\u201327.","journal-title":"Cell"},{"key":"4057_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","volume":"117","author":"S Lopes-Paciencia","year":"2019","unstructured":"Lopes-Paciencia S, Saint-Germain E, Rowell M-C, Ruiz AF, Kalegari P, Ferbeyre G. The senescence-associated secretory phenotype and its regulation. Cytokine. 2019;117:15\u201322.","journal-title":"Cytokine"},{"key":"4057_CR58","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1681\/ASN.2018121251","volume":"30 5","author":"MH Docherty","year":"2019","unstructured":"Docherty MH, O\u2019Sullivan ED, Bonventre JV, Ferenbach DA. Cellular senescence in the kidney. J Am Soc Nephrology: JASN. 2019;30 5:726\u201336.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4057_CR59","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1016\/j.kint.2017.02.036","volume":"92","author":"R Schmitt","year":"2017","unstructured":"Schmitt R, Melk A. Molecular mechanisms of renal aging. Kidney Int. 2017;92:3569\u201379.","journal-title":"Kidney Int"},{"key":"4057_CR60","doi-asserted-by":"publisher","first-page":"2180373","DOI":"10.1155\/2018\/2180373","volume":"2018","author":"S Mihai","year":"2018","unstructured":"Mihai S, Codrici E, Popescu ID, Enciu A-M, Albulescu L, Necula LG, et al. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018;2018:2180373.","journal-title":"J Immunol Res"},{"key":"4057_CR61","doi-asserted-by":"crossref","unstructured":"Chiche A, Le Roux I, von Joest M, Sakai H, Agu\u00edn SB, Cazin C, et al. Injury-induced senescence enables in vivo reprogramming in skeletal muscle. Cell Stem Cell. 2017;20(3):407\u2013\u200914.e4.","DOI":"10.1016\/j.stem.2016.11.020"},{"key":"4057_CR62","doi-asserted-by":"publisher","first-page":"747","DOI":"10.18632\/aging.101425","volume":"10","author":"H Sugihara","year":"2018","unstructured":"Sugihara H, Teramoto N, Yamanouchi K, Matsuwaki T-a, Nishihara M. Oxidative stress-mediated senescence in mesenchymal progenitor cells causes the loss of their fibro\/adipogenic potential and abrogates myoblast fusion. Aging. 2018;10:747\u201363.","journal-title":"Aging"},{"key":"4057_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(03)00550-6","volume":"114","author":"K Masutomi","year":"2003","unstructured":"Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, et al. Telomerase maintains telomere structure in normal human cells. Cell. 2003;114:241\u201353.","journal-title":"Cell"},{"issue":"3","key":"4057_CR64","doi-asserted-by":"publisher","first-page":"H448","DOI":"10.1152\/ajpheart.00287.2018","volume":"315","author":"H Shakeri","year":"2018","unstructured":"Shakeri H, Lemmens K, Gevaert AB, De Meyer GRY, Segers VFM. Cellular senescence links aging and diabetes in cardiovascular disease. Am J Physiol Heart Circ Physiol. 2018;315(3):H448\u201362.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4057_CR65","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/sj.onc.1201862","volume":"16","author":"SJ Robles","year":"1998","unstructured":"Robles SJ, Adami GR. Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene. 1998;16:1113\u201323.","journal-title":"Oncogene"},{"key":"4057_CR66","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"Fagagna FdAd","year":"2008","unstructured":"Fagagna FdAd. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8:512\u201322.","journal-title":"Nat Rev Cancer"},{"key":"4057_CR67","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Mu\u00f1oz-Esp\u00edn","year":"2013","unstructured":"Mu\u00f1oz-Esp\u00edn D, Ca\u00f1amero M, Maraver A, G\u00f3mez-L\u00f3pez G, Contreras J, Murillo-Cuesta S, et al. Programmed cell senescence during mammalian embryonic development. Cell. 2013;155:1104\u201318.","journal-title":"Cell"},{"key":"4057_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T. Cellular senescence: A translational perspective. EBioMedicine. 2017;21:21\u20138.","journal-title":"EBioMedicine"},{"key":"4057_CR69","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1681\/ASN.2016111213","volume":"28 9","author":"B Wang","year":"2017","unstructured":"Wang B, Zhang C, Zhang A, Cai H, Price SR, Wang XH. MicroRNA-23a and MicroRNA-27a mimic exercise by ameliorating CKD-Induced muscle atrophy. J Am Soc Nephrology: JASN. 2017;28 9:2631\u201340.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4057_CR70","first-page":"5329","volume":"125","author":"X Shi","year":"2012","unstructured":"Shi X, Wallis AM, Gerard RD, Voelker KA, Grange RW, DePinho RA, et al. Foxk1 promotes cell proliferation and represses myogenic differentiation by regulating Foxo4 and Mef2. J Cell Sci. 2012;125:5329\u201337.","journal-title":"J Cell Sci"},{"key":"4057_CR71","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1681\/ASN.2015080867","volume":"27 9","author":"J Luo","year":"2016","unstructured":"Luo J, Liang A, Liang M, Xia R, Rizvi YQ, Wang Y, et al. Serum glucocorticoid-regulated kinase 1 blocks CKD-Induced muscle wasting via inactivation of FoxO3a and Smad2\/3. J Am Soc Nephrology: JASN. 2016;27 9:2797\u2013808.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4057_CR72","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-10-2616","volume":"17","author":"JC Montero","year":"2011","unstructured":"Montero JC, Seoane S, Oca\u00f1a A, Pandiella A. Inhibition of Src family kinases and receptor tyrosine kinases by Dasatinib: possible combinations in solid tumors. Clin Cancer Res. 2011;17:5546\u201352.","journal-title":"Clin Cancer Res"},{"key":"4057_CR73","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020;288:518\u201336.","journal-title":"J Intern Med"},{"key":"4057_CR74","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze NG, et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644\u201358.","journal-title":"Aging Cell"},{"key":"4057_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41581-021-00498-0","volume":"18","author":"XH Wang","year":"2021","unstructured":"Wang XH, Mitch WE, Price SR. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol. 2021;18:138\u201352.","journal-title":"Nat Rev Nephrol"},{"key":"4057_CR76","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.13112","volume":"14","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wang B, Hassounah F, Price SR, Klein JD, Mohamed TMA, et al. The impact of senescence on muscle wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2022;14:126\u201341.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"4057_CR77","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.120.14594","volume":"76","author":"Y Li","year":"2020","unstructured":"Li Y, Lerman LO. Cellular senescence: A new player in kidney injury. Hypertension. 2020;76(4):1069\u201375.","journal-title":"Hypertension"},{"key":"4057_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI135821","volume":"131","author":"F Solagna","year":"2021","unstructured":"Solagna F, Tezze C, Lindenmeyer MT, Lu S, Wu G, Liu S, et al. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs. J Clin Investig. 2021;131:11.","journal-title":"J Clin Investig"},{"key":"4057_CR79","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000516371","volume":"7","author":"M Adamczak","year":"2021","unstructured":"Adamczak M, Surma S. Metabolic acidosis in patients with CKD: epidemiology, pathogenesis, and treatment. Kidney Dis. 2021;7:452\u201367.","journal-title":"Kidney Dis"},{"key":"4057_CR80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","volume":"98","author":"O Rom","year":"2016","unstructured":"Rom O, Reznick AZ. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass. Free Radic Biol Med. 2016;98:218\u201330.","journal-title":"Free Radic Biol Med"},{"key":"4057_CR81","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-981-13-1435-3_18","volume":"1088","author":"J Schardong","year":"2018","unstructured":"Schardong J, Marcolino MAZ, Plentz RDM. Muscle atrophy in chronic kidney disease. Adv Exp Med Biol. 2018;1088:393\u2013412.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4057_CR82","doi-asserted-by":"publisher","first-page":"15298","DOI":"10.1038\/s41598-019-50889-4","volume":"9","author":"PR Somvanshi","year":"2019","unstructured":"Somvanshi PR, Tomar M, Kareenhalli V. Computational analysis of insulin-glucagon signalling network: implications of bistability to metabolic homeostasis and disease States. Sci Rep. 2019;9(1):15298.","journal-title":"Sci Rep"},{"issue":"6","key":"4057_CR83","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiology-Renal Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiology-Renal Physiol"},{"issue":"3","key":"4057_CR84","first-page":"154","volume":"36","author":"P Younessi","year":"2011","unstructured":"Younessi P, Yoonessi A. Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci. 2011;36(3):154.","journal-title":"Iran J Med Sci"},{"issue":"5","key":"4057_CR85","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.kint.2016.03.003","volume":"89","author":"CM Wyatt","year":"2016","unstructured":"Wyatt CM, Mitch WE. In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia. Kidney Int. 2016;89(5):973\u20135.","journal-title":"Kidney Int"},{"issue":"2","key":"4057_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","volume":"23","author":"S Kir","year":"2016","unstructured":"Kir S, Komaba H, Garcia AP, Economopoulos KP, Liu W, Lanske B, et al. PTH\/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metabol. 2016;23(2):315\u201323.","journal-title":"Cell Metabol"},{"issue":"1","key":"4057_CR87","first-page":"98","volume":"37","author":"Souza VAd","year":"2015","unstructured":"Souza VAd, Oliveira Dd, Mansur HN, Fernandes NMS, Bastos MG. Sarcopenia in chronic kidney disease. Jornal Brasileiro De Nefrologia: \u2018orgao Oficial De Sociedades Brasileira E Latino-Americana De Nefrologia. 2015;37(1):98\u2013105.","journal-title":"Jornal Brasileiro De Nefrologia: \u2018orgao Oficial De Sociedades Brasileira E Latino-Americana De Nefrologia"},{"key":"4057_CR88","doi-asserted-by":"crossref","unstructured":"Yu M, Zhang H-Z, Zhang Y, Yang S-P, Lin M, Zhang Y-m, et al. Relationship between chronic kidney disease and sarcopenia. Sci Rep. 2021;11.","DOI":"10.1038\/s41598-021-99592-3"},{"key":"4057_CR89","doi-asserted-by":"publisher","first-page":"11126","DOI":"10.3390\/ijms150611126","volume":"15","author":"H Sun","year":"2014","unstructured":"Sun H, Gong Y-P, Qiu J, Chen Y, Ding F, Zhao Q. TRAF6 Inhibition rescues Dexamethasone-Induced muscle atrophy. Int J Mol Sci. 2014;15:11126\u201341.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4057_CR90","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/ndt\/gfv122","volume":"31","author":"P Stenvinkel","year":"2016","unstructured":"Stenvinkel P, Carrero JJ, von Walden F, Ikizler TA, Nader GA. Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol Dial Transplant. 2016;31(7):1070\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"4057_CR91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.steroids.2017.05.012","volume":"124","author":"L Pronsato","year":"2017","unstructured":"Pronsato L, Milanesi LM, Vasconsuelo A, Colla AL. Testosterone modulates FoxO3a and p53-related genes to protect C2C12 skeletal muscle cells against apoptosis. Steroids. 2017;124:35\u201345.","journal-title":"Steroids"},{"key":"4057_CR92","doi-asserted-by":"publisher","first-page":"621226","DOI":"10.3389\/fphys.2020.621226","volume":"11","author":"N Gharahdaghi","year":"2021","unstructured":"Gharahdaghi N, Phillips BE, Szewczyk NJ, Smith K, Wilkinson DJ, Atherton PJ. Links between testosterone, oestrogen, and the growth Hormone\/Insulin-Like growth factor Axis and resistance exercise muscle adaptations. Front Physiol. 2021;11:621226.","journal-title":"Front Physiol"},{"issue":"1","key":"4057_CR93","first-page":"8884283","volume":"2021","author":"D Yu","year":"2021","unstructured":"Yu D, Cai Z, Li D, Zhang Y, He M, Yang Y, et al. Myogenic differentiation of stem cells for skeletal muscle regeneration. Stem Cells Int. 2021;2021(1):8884283.","journal-title":"Stem Cells Int"},{"issue":"3","key":"4057_CR94","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1681\/ASN.2009060571","volume":"21","author":"L Zhang","year":"2010","unstructured":"Zhang L, Wang XH, Wang H, Du J, Mitch WE. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol. 2010;21(3):419\u201327.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4057_CR95","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/CIRCRESAHA.107.162800","volume":"102","author":"AK Doughan","year":"2007","unstructured":"Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-Mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circul Res. 2007;102(4):488\u201396.","journal-title":"Circul Res"},{"key":"4057_CR96","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm1536","volume":"13","author":"RD Cohn","year":"2007","unstructured":"Cohn RD, Erp Cv, Habashi JP, Soleimani A, Klein EC, Lisi MT, et al. Angiotensin II type 1 receptor blockade attenuates TGF-\u03b2\u2013induced failure of muscle regeneration in multiple myopathic states. Nat Med. 2007;13:204\u201310.","journal-title":"Nat Med"},{"issue":"6","key":"4057_CR97","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10157-010-0340-x","volume":"14","author":"HJ Kim","year":"2010","unstructured":"Kim HJ, Vaziri ND, Norris K, An WS, Quiroz Y, Rodriguez-Iturbe B. High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol. 2010;14(6):536\u201347.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"4057_CR98","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1210\/en.2013-1205","volume":"155","author":"CM Girgis","year":"2014","unstructured":"Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng KJ, Gunton JE. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology. 2014;155(2):347\u201357.","journal-title":"Endocrinology"},{"key":"4057_CR99","doi-asserted-by":"publisher","first-page":"105861","DOI":"10.1016\/j.jsbmb.2021.105861","volume":"210","author":"EL Watson","year":"2020","unstructured":"Watson EL, Wilkinson TJ, O\u2019Sullivan TF, Baker LA, Gould DW, Xenophontos S, et al. Association between vitamin D deficiency and exercise capacity in patients with CKD, a cross-sectional analysis. J Steroid Biochem Mol Biol. 2020;210:105861.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"4057_CR100","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, \u0141awi\u0144ski J, Olszewski R, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. The impact of CKD on uremic toxins and gut microbiota. Toxins. 2021;13(4):252.","journal-title":"Toxins"},{"key":"4057_CR101","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1007\/s00018-014-1689-x","volume":"71","author":"J Rodriguez","year":"2014","unstructured":"Rodriguez J, Vernus B, Chelh I, Cassar-Malek I, Gabillard J-C, Hadj Sassi A, et al. Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci. 2014;71:4361\u201371.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4057_CR102","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/ASN.2012050503","volume":"24","author":"L Koppe","year":"2013","unstructured":"Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol. 2013;24(1):88\u201399.","journal-title":"J Am Soc Nephrol"},{"key":"4057_CR103","doi-asserted-by":"publisher","first-page":"32084","DOI":"10.1038\/srep32084","volume":"6","author":"Y Enoki","year":"2016","unstructured":"Enoki Y, Watanabe H, Arake R, Sugimoto R, Imafuku T, Tominaga Y, et al. Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Sci Rep. 2016;6:32084.","journal-title":"Sci Rep"},{"issue":"7","key":"4057_CR104","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/toxins13070472","volume":"13","author":"E Margiotta","year":"2021","unstructured":"Margiotta E, Caldiroli L, Callegari ML, Miragoli F, Zanoni F, Armelloni S, et al. Association of sarcopenia and gut microbiota composition in older patients with advanced chronic kidney disease, investigation of the interactions with uremic toxins, inflammation and oxidative stress. Toxins. 2021;13(7):472.","journal-title":"Toxins"},{"issue":"3","key":"4057_CR105","doi-asserted-by":"publisher","first-page":"e0281745","DOI":"10.1371\/journal.pone.0281745","volume":"18","author":"T Inatomi","year":"2023","unstructured":"Inatomi T, Honma M. Ameliorating effect of probiotics in a rat model of chronic kidney disease. PLoS ONE. 2023;18(3):e0281745.","journal-title":"PLoS ONE"},{"issue":"4","key":"4057_CR106","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/toxins14040263","volume":"14","author":"S Todoriki","year":"2022","unstructured":"Todoriki S, Hosoda Y, Yamamoto T, Watanabe M, Sekimoto A, Sato H, et al. Methylglyoxal induces inflammation, metabolic modulation and oxidative stress in myoblast cells. Toxins. 2022;14(4):263.","journal-title":"Toxins"},{"key":"4057_CR107","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbi.2019.02.023","volume":"304","author":"C-Y Changchien","year":"2019","unstructured":"Changchien C-Y, Lin YH, Cheng Y-C, Chang H-H, Peng Y-S, Chen Y. Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades. Chemico-Biol Interact. 2019;304:43\u201351.","journal-title":"Chemico-Biol Interact"},{"issue":"3","key":"4057_CR108","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MNH.0000000000000700","volume":"30","author":"M Chalupsky","year":"2021","unstructured":"Chalupsky M, Goodson DA, Gamboa JL, Roshanravan B. New insights into muscle function in chronic kidney disease and metabolic acidosis. Curr Opin Nephrol Hypertens. 2021;30(3):369\u201376.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"4057_CR109","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/jcsm.12376","volume":"10","author":"J Aniort","year":"2019","unstructured":"Aniort J, Stella A, Philipponnet C, Poyet A, Polge C, Claustre A, et al. Muscle wasting in patients with end-stage renal disease or early\u2010stage lung cancer: common mechanisms at work. J Cachexia Sarcopenia Muscle. 2019;10:323\u201337.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR110","doi-asserted-by":"publisher","first-page":"701386","DOI":"10.3389\/fnut.2021.701386","volume":"8","author":"G Garibotto","year":"2021","unstructured":"Garibotto G, Saio M, Aimasso F, Russo E, Picciotto D, Viazzi F, et al. How to overcome anabolic resistance in dialysis-treated patients?? Front Nutr. 2021;8:701386.","journal-title":"Front Nutr"},{"key":"4057_CR111","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/jcsm.12781","volume":"12","author":"L Genton","year":"2021","unstructured":"Genton L, Pruijm M, Teta D, Bassi I, Cani PD, Ga\u00efa N, et al. Gut barrier and microbiota changes with glycine and branched-chain amino acid supplementation in chronic haemodialysis patients. J Cachexia Sarcopenia Muscle. 2021;12:1527\u201339.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"4057_CR112","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/sports10030042","volume":"10","author":"H Arazi","year":"2022","unstructured":"Arazi H, Mohabbat M, Saidie P, Falahati A, Suzuki K. Effects of different types of exercise on kidney diseases. Sports. 2022;10(3):42.","journal-title":"Sports"},{"issue":"1","key":"4057_CR113","doi-asserted-by":"publisher","first-page":"14808","DOI":"10.1038\/s41598-020-71755-8","volume":"10","author":"H Westphalen","year":"2020","unstructured":"Westphalen H, Saadati S, Eduok U, Abdelrasoul A, Shoker A, Choi P, et al. Case studies of clinical hemodialysis membranes: influences of membrane morphology and biocompatibility on uremic blood-membrane interactions and inflammatory biomarkers. Sci Rep. 2020;10(1):14808.","journal-title":"Sci Rep"},{"issue":"9","key":"4057_CR114","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/ndt\/gfz193","volume":"35","author":"KA Robinson","year":"2020","unstructured":"Robinson KA, Baker LA, Graham-Brown MPM, Watson EL. Skeletal muscle wasting in chronic kidney disease: the emerging role of MicroRNAs. Nephrol Dial Transplant. 2020;35(9):1469\u201378.","journal-title":"Nephrol Dial Transplant"},{"key":"4057_CR115","doi-asserted-by":"publisher","first-page":"13590","DOI":"10.1096\/fj.201900884R","volume":"33","author":"A Zhang","year":"2019","unstructured":"Zhang A, Wang H, Wang B, Yuan Y, Klein JD, Wang XH. Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease. FASEB J. 2019;33:13590\u2013601.","journal-title":"FASEB J"},{"issue":"3","key":"4057_CR116","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ymthe.2019.01.008","volume":"27","author":"H Wang","year":"2019","unstructured":"Wang H, Wang B, Zhang A, Hassounah F, Seow Y, Wood MJA, et al. Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther. 2019;27(3):571\u201383.","journal-title":"Mol Ther"},{"key":"4057_CR117","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1681\/ASN.2010121278","volume":"22 11","author":"XH Wang","year":"2011","unstructured":"Wang XH, Hu Z, Klein JD, Zhang L, Fang F, Mitch WE. Decreased miR-29 suppresses myogenesis in CKD. J Am Soc Nephrology: JASN. 2011;22 11:2068\u201376.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"4057_CR118","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","volume":"28","author":"JL Chen","year":"2014","unstructured":"Chen JL, Walton KL, Winbanks CE, Murphy KT, Thomson RE, Makanji Y, et al. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J. 2014;28(4):1711\u201323.","journal-title":"FASEB J"},{"key":"4057_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2021.04.001","volume":"60","author":"A Lodberg","year":"2021","unstructured":"Lodberg A. Principles of the activin receptor signaling pathway and its Inhibition. Cytokine Growth Factor Rev. 2021;60:1\u201317.","journal-title":"Cytokine Growth Factor Rev"},{"key":"4057_CR120","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/jcsm.12603","volume":"11","author":"S von Haehling","year":"2020","unstructured":"von Haehling S, Garfias Macedo T, Valentova M, Anker MS, Ebner N, Bekfani T, et al. Muscle wasting as an independent predictor of survival in patients with chronic heart failure. J Cachexia Sarcopenia Muscle. 2020;11:1242\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR121","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/jcsm.12529","volume":"11","author":"LBM Weerink","year":"2020","unstructured":"Weerink LBM, van der Hoorn A, van Leeuwen BL, de Bock GH. Low skeletal muscle mass and postoperative morbidity in surgical oncology: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11:636\u201349.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR122","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jcsm.12524","volume":"11","author":"C-Y Huang","year":"2020","unstructured":"Huang C-Y, Yang YC, Chen T-C, Chen J-R, Chen Y-J, Wu M-H, et al. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. J Cachexia Sarcopenia Muscle. 2020;11:534\u201346.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR123","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jcsm.12349","volume":"9","author":"M Ebadi","year":"2018","unstructured":"Ebadi M, Wang CW, Lai JC, Dasarathy S, Kappus MR, Dunn MA, et al. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis. J Cachexia Sarcopenia Muscle. 2018;9:1053\u201362.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR124","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano D, Messina C, Vitale J, Sconfienza LM. Imaging of sarcopenia: old evidence and new insights. Eur Radiol. 2020;30:2199\u2013208.","journal-title":"Eur Radiol"},{"issue":"1","key":"4057_CR125","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12882-023-03445-2","volume":"25","author":"Q Yang","year":"2024","unstructured":"Yang Q, Zhang C, Zhang Z, Su B. Muscle ultrasound to diagnose sarcopenia in chronic kidney disease: a systematic review and bayesian bivariate meta-analysis. BMC Nephrol. 2024;25(1):12.","journal-title":"BMC Nephrol"},{"issue":"4","key":"4057_CR126","first-page":"225","volume":"129","author":"M Grucha\u0142a-Niedoszytko","year":"2019","unstructured":"Grucha\u0142a-Niedoszytko M, Niedoszytko P, Kaczkan M, Pieszko M, Gierat-Haponiuk K, \u015aliwi\u0144ska A, et al. Cardiopulmonary exercise test and bioimpedance as prediction tools to predict the outcomes of obesity treatment. Pol Archives Intern Med. 2019;129(4):225\u201333.","journal-title":"Pol Archives Intern Med"},{"issue":"2","key":"4057_CR127","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1634\/theoncologist.2019-0600","volume":"25","author":"GFP Aleixo","year":"2019","unstructured":"Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Battaglini C, Williams GR. Bioelectrical impedance analysis for the assessment of sarcopenia in patients with cancer: A systematic review. Oncologist. 2019;25(2):170\u201382.","journal-title":"Oncologist"},{"key":"4057_CR128","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1002\/ehf2.13402","volume":"8","author":"PN Shah","year":"2021","unstructured":"Shah PN, Abel AAI, Boyalla V, Pellicori P, Kallvikbacka-Bennett A, Sze S, et al. A comparison of non\u2010invasive methods of measuring body composition in patients with heart failure: a report from SICA\u2010HF. ESC Heart Fail. 2021;8:3929\u201334.","journal-title":"ESC Heart Fail"},{"key":"4057_CR129","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/jcsm.12641","volume":"11","author":"S Palus","year":"2020","unstructured":"Palus S, Springer J. Biomarkers for cancer cachexia: where do we stand? J Cachexia Sarcopenia Muscle. 2020;11:1388\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR130","doi-asserted-by":"publisher","first-page":"828880","DOI":"10.3389\/fnut.2022.828880","volume":"9","author":"Y-L Lin","year":"2022","unstructured":"Lin Y-L, Wang C-H, Chang I-C, Hsu B-G. A novel application of serum creatinine and Cystatin C to predict sarcopenia in advanced CKD. Front Nutr. 2022;9:828880.","journal-title":"Front Nutr"},{"issue":"5","key":"4057_CR131","doi-asserted-by":"publisher","first-page":"580","DOI":"10.23876\/j.krcp.21.214","volume":"41","author":"JN An","year":"2022","unstructured":"An JN, Kim J-K, Lee H-S, Kim SG, Kim HJ, Song YR. Serum Cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease. Kidney Res Clin Pract. 2022;41(5):580.","journal-title":"Kidney Res Clin Pract"},{"issue":"3","key":"4057_CR132","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases10030042","volume":"10","author":"SK Papadopoulou","year":"2022","unstructured":"Papadopoulou SK, Voulgaridou G, Kondyli FS, Drakaki M, Sianidou K, Andrianopoulou R, et al. Nutritional and nutrition-related biomarkers as prognostic factors of sarcopenia, and their role in disease progression. Diseases. 2022;10(3):42.","journal-title":"Diseases"},{"issue":"3","key":"4057_CR133","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1389450043490505","volume":"5","author":"JMAV Argil\u00e9s","year":"2004","unstructured":"Argil\u00e9s JMAV, Busquets S, L\u00f3pez-Soriano FJ. The Pharmacological treatment of cachexia. Curr Drug Targets. 2004;5(3):265\u201377.","journal-title":"Curr Drug Targets"},{"issue":"8","key":"4057_CR134","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/ncpendmet0221","volume":"2","author":"MD DeBoer","year":"2006","unstructured":"DeBoer MD, Marks DL. Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease. Nat Clin Pract Endocrinol Metab. 2006;2(8):459\u201366.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"4","key":"4057_CR135","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/SPC.0000000000000217","volume":"10","author":"RH Mak","year":"2016","unstructured":"Mak RH. Cachexia in children with chronic kidney disease: challenges in diagnosis and treatment. Curr Opin Support Palliat Care. 2016;10(4):293\u20137.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"6","key":"4057_CR136","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/MNH.0b013e3282f02204","volume":"16","author":"RH Mak","year":"2007","unstructured":"Mak RH, Cheung W. Therapeutic strategy for cachexia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2007;16(6):542\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"4057_CR137","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1051-2276(97)90035-2","volume":"4","author":"JL Williams","year":"1997","unstructured":"Williams JL, Perius M, Humble A, Sigler D, Urbanes A, Shapiro HS. Effect of megestrol acetate on the nutritional status of malnourished Hemodialysis patients. J Ren Nutr. 1997;4(7):231.","journal-title":"J Ren Nutr"},{"issue":"5","key":"4057_CR138","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1515\/JPEM.2009.22.5.425","volume":"22","author":"P Mahachoklertwattana","year":"2009","unstructured":"Mahachoklertwattana P, Wanasuwankul S, Poomthavorn P, Choubtum L, Sriphrapradang A. Short-term Cyproheptadine therapy in underweight children: effects on growth and serum insulin-like growth factor-I. J Pediatr Endocrinol Metabolism. 2009;22(5):425\u201332.","journal-title":"J Pediatr Endocrinol Metabolism"},{"issue":"9","key":"4057_CR139","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.nut.2008.06.013","volume":"24","author":"MD DeBoer","year":"2008","unstructured":"DeBoer MD. Emergence of Ghrelin as a treatment for cachexia syndromes. Nutrition. 2008;24(9):806\u201314.","journal-title":"Nutrition"},{"issue":"2","key":"4057_CR140","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/en.2007-1046","volume":"149","author":"MD DeBoer","year":"2008","unstructured":"DeBoer MD, Zhu X, Levasseur PR, Inui A, Hu Z, Han G, et al. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 2008;149(2):827\u201335.","journal-title":"Endocrinology"},{"issue":"7","key":"4057_CR141","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1681\/ASN.2005010039","volume":"16","author":"K Wynne","year":"2005","unstructured":"Wynne K, Giannitsopoulou K, Small CJ, Patterson M, Frost G, Ghatei MA, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 2005;16(7):2111\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"4057_CR142","doi-asserted-by":"crossref","unstructured":"Ashby D, Choi P, Bloom S. Ghrelin in cachexia associated with end-stage renal disease. Ghrelin in Health and Disease. 2012. pp. 231\u2013\u200956.","DOI":"10.1007\/978-1-61779-903-7_13"},{"issue":"5","key":"4057_CR143","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/sj.ki.5000182","volume":"69","author":"RH Mak","year":"2006","unstructured":"Mak RH, Cheung W, Cone RD, Marks DL. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int. 2006;69(5):794\u20137.","journal-title":"Kidney Int"},{"issue":"12","key":"4057_CR144","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1093\/ndt\/gfi192","volume":"20","author":"A Wiecek","year":"2005","unstructured":"Wiecek A. How does leptin contribute to uraemic cachexia? Nephrol Dialysis Transplantation. 2005;20(12):2620\u20132.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"2","key":"4057_CR145","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nut.2009.07.003","volume":"26","author":"MD DeBoer","year":"2010","unstructured":"DeBoer MD. Update on melanocortin interventions for cachexia: progress toward clinical application. Nutrition. 2010;26(2):146\u201351.","journal-title":"Nutrition"},{"issue":"2","key":"4057_CR146","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ki.2008.150","volume":"74","author":"WW Cheung","year":"2008","unstructured":"Cheung WW, Rosengren S, Boyle DL, Mak RH. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int. 2008;74(2):180\u20136.","journal-title":"Kidney Int"},{"issue":"1","key":"4057_CR147","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1681\/ASN.2013040432","volume":"25","author":"WW Cheung","year":"2014","unstructured":"Cheung WW, Ding W, Gunta SS, Gu Y, Tabakman R, Klapper LN, et al. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice. J Am Soc Nephrol. 2014;25(1):119\u201328.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4057_CR148","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.2174\/1381612824666180125094921","volume":"24","author":"RH Mak","year":"2018","unstructured":"Mak RH, Cheung WW, Solomon G, Gertler A. Preparation of potent leptin receptor antagonists and their therapeutic use in mouse models of uremic cachexia and kidney fibrosis. Curr Pharm Design. 2018;24(9):1012\u20138.","journal-title":"Curr Pharm Design"},{"issue":"9","key":"4057_CR149","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1681\/ASN.2006091024","volume":"18","author":"WW Cheung","year":"2007","unstructured":"Cheung WW, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, et al. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol. 2007;18(9):2517\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"4057_CR150","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.ajkd.2014.02.022","volume":"64","author":"S Headley","year":"2014","unstructured":"Headley S, Germain M, Wood R, Joubert J, Milch C, Evans E, et al. Short-term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial. Am J Kidney Dis. 2014;64(2):222\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4057_CR151","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/ndt\/gft529","volume":"29","author":"F Baria","year":"2014","unstructured":"Baria F, Kamimura MA, Aoike DT, Ammirati A, Leister Rocha M, de Mello MT, et al. Randomized controlled trial to evaluate the impact of aerobic exercise on visceral fat in overweight chronic kidney disease patients. Nephrol Dialysis Transplantation. 2014;29(4):857\u201364.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"4","key":"4057_CR152","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s11255-010-9823-7","volume":"43","author":"S Mustata","year":"2011","unstructured":"Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B. Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol. 2011;43(4):1133\u201341.","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"4057_CR153","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1681\/ASN.2013070702","volume":"25","author":"JL Viana","year":"2014","unstructured":"Viana JL, Kosmadakis GC, Watson EL, Bevington A, Feehally J, Bishop NC, et al. Evidence for anti-inflammatory effects of exercise in CKD. J Am Soc Nephrol. 2014;25(9):2121\u201330.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"4057_CR154","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00421-013-2628-5","volume":"113","author":"EL Watson","year":"2013","unstructured":"Watson EL, Kosmadakis GC, Smith AC, Viana JL, Brown JR, Molyneux K, et al. Combined walking exercise and alkali therapy in patients with CKD4\u20135 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression. Eur J Appl Physiol. 2013;113(8):2111\u201324.","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"4057_CR155","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcsm.12088","volume":"6","author":"SD Anker","year":"2015","unstructured":"Anker SD, Morley JE. Cachexia: a nutritional syndrome? J Cachexia Sarcopenia Muscle. 2015;6(4):269\u201371.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4057_CR156","doi-asserted-by":"publisher","first-page":"2789014","DOI":"10.1155\/2019\/2789014","volume":"2019","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Bi X, Hu C, Ding F, Ding W. Therapeutic approaches in mitochondrial dysfunction, inflammation, and autophagy in uremic cachexia: role of aerobic exercise. Mediat Inflamm. 2019;2019:2789014.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"4057_CR157","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.ajkd.2014.10.019","volume":"66","author":"EL Watson","year":"2015","unstructured":"Watson EL, Greening NJ, Viana JL, Aulakh J, Bodicoat DH, Barratt J, et al. Progressive resistance exercise training in CKD: a feasibility study. Am J Kidney Dis. 2015;66(2):249\u201357.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4057_CR158","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/00007890-200207150-00008","volume":"74","author":"PL Painter","year":"2002","unstructured":"Painter PL, Hector L, Ray K, Lynes L, Dibble S, Paul SM, et al. A randomized trial of exercise training after renal transplantation. Transplantation. 2002;74(1):42\u20138.","journal-title":"Transplantation"},{"issue":"10","key":"4057_CR159","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/ndt\/gfu248","volume":"29","author":"C Bohm","year":"2014","unstructured":"Bohm C, Stewart K, Onyskie-Marcus J, Esliger D, Kriellaars D, Rigatto C. Effects of intradialytic cycling compared with pedometry on physical function in chronic outpatient hemodialysis: a prospective randomized trial. Nephrol Dialysis Transplantation. 2014;29(10):1947\u201355.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"6","key":"4057_CR160","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/jcsm.12791","volume":"12","author":"H Noor","year":"2021","unstructured":"Noor H, Reid J, Slee A. Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review. J Cachexia Sarcopenia Muscle. 2021;12(6):1621\u201340.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"4057_CR161","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00467-004-1789-1","volume":"20","author":"RH Mak","year":"2005","unstructured":"Mak RH, Cheung W, Cone RD, Marks DL. Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol. 2005;20(3):427\u201331.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"4057_CR162","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4103\/2230-8210.93743","volume":"16","author":"YP Jadeja","year":"2012","unstructured":"Jadeja YP, Kher V. Protein energy wasting in chronic kidney disease: an update with focus on nutritional interventions to improve outcomes. Indian J Endocrinol Metabol. 2012;16(2):246\u201351.","journal-title":"Indian J Endocrinol Metabol"},{"issue":"6","key":"4057_CR163","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/sdi.12832","volume":"32","author":"EA Oliveira","year":"2019","unstructured":"Oliveira EA, Zheng R, Carter CE, Mak RH. Cachexia\/Protein energy wasting syndrome in CKD: causation and treatment. Semin Dial. 2019;32(6):493\u20139.","journal-title":"Semin Dial"},{"issue":"11","key":"4057_CR164","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nrneph.2011.137","volume":"7","author":"L Rees","year":"2011","unstructured":"Rees L, Mak RH. Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol. 2011;7(11):615\u201323.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"4057_CR165","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1007\/s00467-006-0235-y","volume":"21","author":"R Rashid","year":"2006","unstructured":"Rashid R, Neill E, Smith W, King D, Beattie TJ, Murphy A, et al. Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol. 2006;21(11):1730\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"4057_CR166","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1172\/JCI0215449","volume":"110","author":"LB Pupim","year":"2002","unstructured":"Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic Hemodialysis patients. J Clin Investig. 2002;110(4):483\u201392.","journal-title":"J Clin Investig"},{"issue":"5","key":"4057_CR167","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1053\/ajkd.2002.32775","volume":"39","author":"NG Kutner","year":"2002","unstructured":"Kutner NG, Clow PW, Zhang R, Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 2002;39(5):1018\u201324.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4057_CR168","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13539-011-0019-5","volume":"2","author":"RH Mak","year":"2011","unstructured":"Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011;2(1):9\u201325.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"4057_CR169","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/nu13010147","volume":"13","author":"A Noce","year":"2021","unstructured":"Noce A, Marrone G, Ottaviani E, Guerriero C, Di Daniele F, Pietroboni Zaitseva A, et al. Uremic sarcopenia and its possible nutritional approach. Nutrients. 2021;13(1):147.","journal-title":"Nutrients"},{"issue":"5","key":"4057_CR170","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2215\/CJN.08340812","volume":"8","author":"MK Abramowitz","year":"2013","unstructured":"Abramowitz MK, Melamed ML, Bauer C, Raff AC, Hostetter TH. Effects of oral sodium bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2013;8(5):714\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"4057_CR171","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.3390\/cells10123382","volume":"10","author":"RH Mak","year":"2021","unstructured":"Mak RH, Querfeld U, Gonzalez A, Gunta S, Cheung WW. Differential effects of 25-Hydroxyvitamin D3 versus 1alpha 25-Dihydroxyvitamin D3 on adipose tissue Browning in CKD-Associated Cachexia. Cells. 2021;10(12):3382.","journal-title":"Cells"},{"issue":"6","key":"4057_CR172","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","volume":"12","author":"O Gungor","year":"2021","unstructured":"Gungor O, Ulu S, Hasbal NB, Anker SD, Kalantar-Zadeh K. Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do? J Cachexia Sarcopenia Muscle. 2021;12(6):1380\u201392.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"4057_CR173","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/etm.2017.4492","volume":"14","author":"Z Geng","year":"2017","unstructured":"Geng Z, Wei L, Zhang C, Yan X. Astragalus polysaccharide, a component of traditional Chinese medicine, inhibits muscle cell atrophy (cachexia) in an in vivo and in vitro rat model of chronic renal failure by activating the ubiquitin-proteasome pathway. Experimental Therapeutic Med. 2017;14(1):91\u20136.","journal-title":"Experimental Therapeutic Med"},{"issue":"24","key":"4057_CR174","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1111\/jcmm.17626","volume":"26","author":"T Pei","year":"2022","unstructured":"Pei T, Zhu D, Yang S, Hu R, Wang F, Zhang J, et al. Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut-renal muscle axis. J Cell Mol Med. 2022;26(24):6066\u201378.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4057_CR175","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Reviews Endocrinol. 2015;11(10):577\u201391.","journal-title":"Nat Reviews Endocrinol"},{"key":"4057_CR176","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00726-017-2493-3","volume":"49","author":"R Lin","year":"2017","unstructured":"Lin R, Liu W, Piao M, Zhu H. A review of the relationship between the gut microbiota and amino acid metabolism. Amino Acids. 2017;49:2083\u201390.","journal-title":"Amino Acids"},{"key":"4057_CR177","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10974-015-9439-8","volume":"36","author":"C Malavaki","year":"2015","unstructured":"Malavaki C, Sakkas GK, Mitrou G, Kalyva A, Stefanidis I, Myburgh K, et al. Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy. J Muscle Res Cell Motil. 2015;36:405\u201321.","journal-title":"J Muscle Res Cell Motil"},{"key":"4057_CR178","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fcimb.2019.00305","volume":"9","author":"L Genton","year":"2019","unstructured":"Genton L, Mareschal J, Charretier Y, Lazarevic V, Bindels LB, Schrenzel J. Targeting the gut microbiota to treat Cachexia. Front Cell Infect Microbiol. 2019;9:305.","journal-title":"Front Cell Infect Microbiol"},{"key":"4057_CR179","doi-asserted-by":"publisher","first-page":"876078","DOI":"10.3389\/fphys.2022.876078","volume":"13","author":"MH Baig","year":"2022","unstructured":"Baig MH, Ahmad K, Moon JS, Park S-Y, Ho Lim J, Chun HJ, et al. Myostatin and its regulation: a comprehensive review of myostatin inhibiting strategies. Front Physiol. 2022;13:876078.","journal-title":"Front Physiol"},{"issue":"1","key":"4057_CR180","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1038\/ncomms8212","volume":"6","author":"JS Yu","year":"2015","unstructured":"Yu JS, Ramasamy TS, Murphy N, Holt MK, Czapiewski R, Wei S-K, et al. PI3K\/mTORC2 regulates TGF-\u03b2\/Activin signalling by modulating Smad2\/3 activity via linker phosphorylation. Nat Commun. 2015;6(1):7212.","journal-title":"Nat Commun"},{"key":"4057_CR181","doi-asserted-by":"publisher","first-page":"101880","DOI":"10.1016\/j.molmet.2024.101880","volume":"80","author":"E Nunn","year":"2024","unstructured":"Nunn E, Jaiswal N, Gavin M, Uehara K, Stefkovich M, Drareni K, et al. Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Mol Metabolism. 2024;80:101880.","journal-title":"Mol Metabolism"},{"key":"4057_CR182","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrneph.2017.169","volume":"14","author":"P Stenvinkel","year":"2018","unstructured":"Stenvinkel P, Painer J, Kuro-o M, Lanaspa MA, Arnold W, Ruf T, et al. Novel treatment strategies for chronic kidney disease: insights from the animal Kingdom. Nat Rev Nephrol. 2018;14:265\u201384.","journal-title":"Nat Rev Nephrol"},{"key":"4057_CR183","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MCO.0000000000000455","volume":"21","author":"M Francaux","year":"2018","unstructured":"Francaux M, Deldicque L. Using polyphenol derivatives to prevent muscle wasting. Curr Opin Clin Nutr Metab Care. 2018;21:159\u201363.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"4057_CR184","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nu11030496","volume":"11","author":"D Mafra","year":"2019","unstructured":"Mafra D, Borges NA, Alvarenga L, Esgalhado M, Cardozo LFMF, Lindholm B, et al. Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients. 2019;11(3):496.","journal-title":"Nutrients"},{"key":"4057_CR185","doi-asserted-by":"crossref","unstructured":"Zhao Y, Liu X, Fu X-j, Mo Z, Jiang Y, Yan Y. Protective effects of epigallocatechin gallate against ischemia reperfusion injury in rat skeletal muscle via activating Nrf2\/HO-1 signaling pathway. Life Sci. 2019:117014.","DOI":"10.1016\/j.lfs.2019.117014"},{"key":"4057_CR186","doi-asserted-by":"crossref","unstructured":"Golpour P, Nourbakhsh M, Mazaherioun M, Janani L, Nourbakhsh M, Yaghmaei P. Improvement of Nrf2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: a double-blind randomised placebo-controlled clinical trial. Diabetes Res Clin Pract. 2020:108120.","DOI":"10.1016\/j.diabres.2020.108120"},{"issue":"4","key":"4057_CR187","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/md19040182","volume":"19","author":"SH Son","year":"2021","unstructured":"Son SH, Lee SM, Lee MH, Son YK, Kim SE, An WS. Omega-3 fatty acids upregulate SIRT1\/3, activate PGC-1\u03b1 via deacetylation, and induce Nrf1 production in 5\/6 nephrectomy rat model. Mar Drugs. 2021;19(4):182.","journal-title":"Mar Drugs"},{"key":"4057_CR188","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73 4","author":"D Fouque","year":"2008","unstructured":"Fouque D, Kalantar-Zadeh K, Kopple JD, Cano NJM, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73 4:391\u20138.","journal-title":"Kidney Int"},{"issue":"6","key":"4057_CR189","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/j.jrn.2016.06.005","volume":"26","author":"JF Saldanha","year":"2016","unstructured":"Saldanha JF, Leal VO, Rizzetto F, Grimmer GHN, Ribeiro-Alves M, Daleprane JB, et al. Effects of resveratrol supplementation in Nrf2 and NF-\u03baB expressions in nondialyzed chronic kidney disease patients: A randomized, double-blind, placebo-controlled, crossover clinical trial. J Ren Nutr. 2016;26(6):401\u20136.","journal-title":"J Ren Nutr"},{"key":"4057_CR190","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.05.010","volume":"99","author":"V Dutt","year":"2015","unstructured":"Dutt V, Gupta S, Dabur R, Injeti E, Mittal A. Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action. Pharmacol Res. 2015;99:86\u2013100.","journal-title":"Pharmacol Res"},{"key":"4057_CR191","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1055-9965.EPI-07-0022","volume":"16","author":"DJ Boocock","year":"2007","unstructured":"Boocock DJ, Faust GES, Patel KR, Schinas AM, Brown VA, Ducharme MP, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16:1246\u201352.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4057_CR192","doi-asserted-by":"crossref","unstructured":"Yu R, Chen JA, Xu J, Cao J, Wang Y, Thomas SS, Hu Z. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease. J Cachexia Sarcopenia Muscle. 2017;8(2):327-41.","DOI":"10.1002\/jcsm.12162"},{"issue":"6","key":"4057_CR193","first-page":"627","volume":"13","author":"SD Kunkel","year":"2011","unstructured":"Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Dyle MC, et al. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. FASEB J. 2011;13(6):627\u201338.","journal-title":"FASEB J"},{"key":"4057_CR194","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.physbeh.2017.03.040","volume":"176","author":"PE Bunney","year":"2017","unstructured":"Bunney PE, Zink AN, Holm AA, Billington CJ, Kotz CM. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav. 2017;176:139\u201348.","journal-title":"Physiol Behav"},{"issue":"9","key":"4057_CR195","doi-asserted-by":"publisher","first-page":"nzz101","DOI":"10.1093\/cdn\/nzz101","volume":"3","author":"R Kanlaya","year":"2019","unstructured":"Kanlaya R, Thongboonkerd V. Molecular mechanisms of Epigallocatechin-3-Gallate for prevention of chronic kidney disease and renal fibrosis: preclinical evidence. Curr Developments Nutr. 2019;3(9):nzz101.","journal-title":"Curr Developments Nutr"},{"issue":"1","key":"4057_CR196","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2011.02.023","volume":"305","author":"H Wang","year":"2011","unstructured":"Wang H, Lai Y-J, Chan Y-L, Li T-L, Wu C-J. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer Lett. 2011;305(1):40\u20139.","journal-title":"Cancer Lett"},{"key":"4057_CR197","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.freeradbiomed.2017.04.365","volume":"108","author":"W Sun","year":"2017","unstructured":"Sun W, Liu X, Zhang H, Song Y, Li T, Liu X, et al. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free Radic Biol Med. 2017;108:840\u201357.","journal-title":"Free Radic Biol Med"},{"key":"4057_CR198","doi-asserted-by":"publisher","first-page":"2418671","DOI":"10.1155\/2017\/2418671","volume":"2017","author":"X-J Sun","year":"2017","unstructured":"Sun X-J, Liu Y, Li C, Wang X, Zhu R, Liu C, et al. Recent advances of curcumin in the prevention and treatment of renal fibrosis. Biomed Res Int. 2017;2017:2418671.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4057_CR199","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/ijms20051178","volume":"20","author":"CN Receno","year":"2019","unstructured":"Receno CN, Liang C, Korol DL, Atalay M, Heffernan KS, Brutsaert TD, et al. Effects of prolonged dietary curcumin exposure on skeletal muscle biochemical and functional responses of aged male rats. Int J Mol Sci. 2019;20(5):1178.","journal-title":"Int J Mol Sci"},{"key":"4057_CR200","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbacli.2016.02.003","volume":"5","author":"BK McFarlin","year":"2016","unstructured":"McFarlin BK, Venable AS, Henning AL, Sampson JNB, Pennel K, Vingren JL, et al. Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA Clin. 2016;5:72\u20138.","journal-title":"BBA Clin"},{"key":"4057_CR201","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/JIR.S110873","volume":"9","author":"K \u015eahin","year":"2016","unstructured":"\u015eahin K, Pala R, Tuzcu M, Ozdemir O, Orhan C, \u015eahin N, et al. Curcumin prevents muscle damage by regulating NF-\u03baB and Nrf2 pathways and improves performance: an in vivo model. J Inflamm Res. 2016;9:147\u201354.","journal-title":"J Inflamm Res"},{"issue":"4","key":"4057_CR202","doi-asserted-by":"publisher","first-page":"F439","DOI":"10.1152\/ajprenal.00356.2010","volume":"302","author":"SS Ghosh","year":"2012","unstructured":"Ghosh SS, Krieg RJJ, Massey HD, Sica DA, Fakhry I, Ghosh S, et al. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5\/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Ren Physiol. 2012;302(4):F439\u201354.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"4057_CR203","doi-asserted-by":"publisher","first-page":"C475","DOI":"10.1152\/ajpcell.00088.2004","volume":"287","author":"BA Bondesen","year":"2004","unstructured":"Bondesen BA, Mills ST, Kegley KM, Pavlath GK. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol. 2004;287(2):C475\u201383.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"4057_CR204","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1476-5381.2012.01854.x","volume":"166","author":"Y Pan","year":"2012","unstructured":"Pan Y, Wang Y, Cai L, Cai Y, Hu J, Yu C, et al. Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. Br J Pharmacol. 2012;166(3):1169\u201382.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4057_CR205","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/japplphysiol.00654.2018","volume":"126","author":"AM Wafi","year":"2019","unstructured":"Wafi AM, Hong J, Rudebush TL, Yu L, Hackfort BT, Wang H-J, et al. Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle. J Appl Physiol. 2019;126(2):477\u201386.","journal-title":"J Appl Physiol"},{"key":"4057_CR206","doi-asserted-by":"publisher","first-page":"20293","DOI":"10.18632\/oncotarget.7773","volume":"7","author":"HA Parsons","year":"2016","unstructured":"Parsons HA, Baracos VE, Hong DS, Abbruzzese JL, Bruera E, Kurzrock R. The effects of Curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer. Oncotarget. 2016;7:20293\u2013304.","journal-title":"Oncotarget"},{"issue":"2","key":"4057_CR207","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1871530316666160613115221","volume":"16","author":"J He","year":"2016","unstructured":"He J, Xie H, Wu S. Dietary supplementation of Curcumin alleviates NF-\u03baB-dependent skeletal muscle wasting in rat. Endocr Metab Immune Disord Drug Targets. 2016;16(2):140\u20137.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"4057_CR208","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/antiox11061112","volume":"11","author":"AK Aranda-Rivera","year":"2022","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Pedraza-Chaverri J, Scholze A. Nrf2 activation in chronic kidney disease: promises and pitfalls. Antioxidants. 2022;11(6):1112.","journal-title":"Antioxidants"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04057-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04057-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:33:44Z","timestamp":1741862024000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04057-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4057"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04057-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}